Invacare Corporation (NYSE:IVC) is scheduled to release its earnings data after the market closes on Tuesday, November 7th. Analysts expect Invacare Corporation to post earnings of ($0.42) per share for the quarter.

Invacare Corporation (NYSE:IVC) last issued its quarterly earnings results on Monday, August 7th. The health services provider reported ($0.63) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.42) by ($0.21). The company had revenue of $233.50 million for the quarter, compared to analyst estimates of $243.03 million. Invacare Corporation had a negative return on equity of 12.79% and a negative net margin of 6.42%. The firm’s quarterly revenue was down 15.1% on a year-over-year basis. During the same quarter last year, the company earned ($0.33) EPS. On average, analysts expect Invacare Corporation to post $-1.9 EPS for the current fiscal year and $-0.85 EPS for the next fiscal year.

Shares of Invacare Corporation (IVC) traded down 0.32% on Tuesday, reaching $15.60. 153,755 shares of the company traded hands. The firm’s 50 day moving average is $15.14 and its 200 day moving average is $14.08. The company’s market capitalization is $512.77 million. Invacare Corporation has a one year low of $8.90 and a one year high of $16.65.

The firm also recently announced a quarterly dividend, which was paid on Monday, October 16th. Shareholders of record on Thursday, October 5th were given a $0.0125 dividend. This represents a $0.05 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend was Wednesday, October 4th. Invacare Corporation’s dividend payout ratio is presently -2.59%.

TRADEMARK VIOLATION WARNING: This report was originally posted by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. and international trademark & copyright legislation. The original version of this report can be accessed at https://theolympiareport.com/2017/10/31/invacare-corporation-ivc-to-release-earnings-on-tuesday.html.

In other news, SVP Dean J. Childers sold 6,249 shares of the business’s stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $15.15, for a total transaction of $94,672.35. Following the sale, the senior vice president now directly owns 44,875 shares in the company, valued at $679,856.25. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 3.20% of the company’s stock.

A number of research firms have issued reports on IVC. ValuEngine upgraded Invacare Corporation from a “sell” rating to a “hold” rating in a research report on Friday, August 4th. KeyCorp reiterated an “overweight” rating and issued a $17.00 target price on shares of Invacare Corporation in a research report on Tuesday, September 26th. Zacks Investment Research upgraded Invacare Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, October 11th. Finally, BidaskClub cut Invacare Corporation from a “sell” rating to a “strong sell” rating in a report on Wednesday, August 2nd. One analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. Invacare Corporation has a consensus rating of “Hold” and an average target price of $14.50.

Invacare Corporation Company Profile

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Earnings History for Invacare Corporation (NYSE:IVC)

Receive News & Ratings for Invacare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.